- Home
- RPTX vs MPA Comparison
RPTX vs MPA Comparison
Compare RPTX & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- MPA
- Stock Information
- Founded
- RPTX 2016
- MPA 1992
- Country
- RPTX Canada
- MPA United States
- Employees
- RPTX N/A
- MPA N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- MPA Finance Companies
- Sector
- RPTX Health Care
- MPA Finance
- Exchange
- RPTX Nasdaq
- MPA Nasdaq
- Market Cap
- RPTX 155.4M
- MPA 160.3M
- IPO Year
- RPTX 2020
- MPA N/A
- Fundamental
- Price
- RPTX $3.59
- MPA $12.21
- Analyst Decision
- RPTX Strong Buy
- MPA
- Analyst Count
- RPTX 1
- MPA 0
- Target Price
- RPTX $10.00
- MPA N/A
- AVG Volume (30 Days)
- RPTX 71.8K
- MPA 25.2K
- Earning Date
- RPTX 11-07-2024
- MPA 01-01-0001
- Dividend Yield
- RPTX N/A
- MPA 3.83%
- EPS Growth
- RPTX N/A
- MPA N/A
- EPS
- RPTX N/A
- MPA N/A
- Revenue
- RPTX $68,683,000.00
- MPA N/A
- Revenue This Year
- RPTX $16.85
- MPA N/A
- Revenue Next Year
- RPTX N/A
- MPA N/A
- P/E Ratio
- RPTX N/A
- MPA N/A
- Revenue Growth
- RPTX N/A
- MPA N/A
- 52 Week Low
- RPTX $2.71
- MPA $9.87
- 52 Week High
- RPTX $8.49
- MPA $12.21
- Technical
- Relative Strength Index (RSI)
- RPTX 53.00
- MPA 50.51
- Support Level
- RPTX $3.37
- MPA $11.87
- Resistance Level
- RPTX $4.05
- MPA $12.15
- Average True Range (ATR)
- RPTX 0.26
- MPA 0.14
- MACD
- RPTX 0.00
- MPA 0.01
- Stochastic Oscillator
- RPTX 40.65
- MPA 52.31
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About MPA Blackrock MuniYield Pennsylvania Quality Fund
Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.